blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4291557

EP4291557 - COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  17.11.2023
Database last updated on 05.10.2024
FormerThe international publication has been made
Status updated on  19.08.2022
Formerunknown
Status updated on  11.03.2022
Most recent event   Tooltip19.04.2024Change: Validation statespublished on 22.05.2024  [2024/21]
19.04.2024Change - extension statespublished on 22.05.2024  [2024/21]
Applicant(s)For all designated states
Mironid Limited
Arbuthnott Building - Hamnett Wing
161 Cathedral Street
Glasgow G4 0RE / GB
[2023/51]
Inventor(s)01 / ADAM, Julia Mary
Glasgow G4 0RE / GB
02 / ADAMS, David Roger
Glasgow G4 0RE / GB
 [2023/51]
Representative(s)Heller, Benjamin Henry, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2023/51]
Application number, filing date22706880.615.02.2022
[2023/51]
WO2022GB50402
Priority number, dateGB2021000208815.02.2021         Original published format: GB 202102088
[2023/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022172037
Date:18.08.2022
Language:EN
[2022/33]
Type: A1 Application with search report 
No.:EP4291557
Date:20.12.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 18.08.2022 takes the place of the publication of the European patent application.
[2023/51]
Search report(s)International search report - published on:EP18.08.2022
ClassificationIPC:C07D417/04, C07D417/10, C07D471/04, C07D471/10, C07D487/04, C07D487/08, C07D487/10, C07D491/08, A61P29/00, A61P35/00, A61P37/00, A61P43/00, A61K31/4436, A61K31/4535, A61K31/496
[2023/51]
CPC:
C07D417/04 (EP,US); A61P13/12 (US); C07D277/82 (US);
C07D417/14 (EP,US); C07D471/04 (EP,US); C07D471/10 (EP);
C07D471/18 (US); C07D471/20 (US); C07D487/04 (EP);
C07D487/08 (EP); C07D487/10 (EP); C07D491/08 (EP);
C07D498/10 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/51]
TitleGerman:VERBINDUNGEN UND IHRE VERWENDUNG ALS PDE4-AKTIVATOREN[2023/51]
English:COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS[2023/51]
French:COMPOSÉS ET LEUR UTILISATION EN TANT QU'ACTIVATEURS DE PDE4[2023/51]
Entry into regional phase30.08.2023National basic fee paid 
30.08.2023Designation fee(s) paid 
30.08.2023Examination fee paid 
Examination procedure30.08.2023Examination requested  [2023/51]
30.08.2023Date on which the examining division has become responsible
01.02.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
05.01.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2006207785  (ACTELOIN PHARMACEUTICALS LTD.) [A] 1-51 * example 75; claim - *;
 [A]US2009130076  (SINGH JASBIR [US], et al) [A] 1-51* paragraph [[0003]]; example -; claim - *;
 [X]WO2015038503  (DU PONT [US]) [X] 15,16,20,23,24,26,33,35-37,39 * page 106, Table 17a and pages 50-55,Table 1a; page 167 Index Table E, compounds 88 and 126 *;
 [A]EP3020718  (MEIJI SEIKA PHARMA CO LTD [JP]) [A] 1-51 * examples 96-101; claim - *;
 [A]WO2020004521  (MEIJI SEIKA PHARMA CO LTD [JP]) [A] 1-51 * page 1; examples 94. 98-101, 353-358, 385-390; claim - *
by applicantWO2016151300
 WO2018060704
 WO2019193342
    - LUGNIER, C., Pharmacol Ther, (20060000), vol. 109, pages 366 - 398
    - HOUSLAY, M.D., Prog Nucleic Acid Res Mol Biol, (20010000), vol. 69, pages 249 - 315
    - HOUSLAY, M.D.BAILLIE, G.S.MAURICE, D.H., Circ Res, (20070000), vol. 100, pages 950 - 66
    - HOUSLAY, M. D.SCHAFER, P.ZHANG, K., Drug Discovery Today, (20050000), vol. 10, pages 1503 - 1519
    - RICHTER, WCONTI, M, J. Biol. Chem., (20020000), vol. 277, pages 40212 - 40221
    - BOLGER, G. B., Cell. Signal., (20150000), vol. 27, pages 908 - 922
    - BURGIN A. B., Nat. Biotechnol., (20100000), vol. 28, pages 63 - 70
    - TAKIAR, V.CAPLAN, M., J. Biochim. Biophys. Acta, (20110000), vol. 1812, pages 1337 - 1343
    - MACKENZIE, S. J. et al., Br. J. Pharmacol., (20020000), vol. 136, pages 421 - 433
    - GRANGE et al., J. Biol. Chem., (20000000), vol. 275, pages 33379 - 33387
    - OMAR et al., PNAS, (20190000), vol. 116, pages 13320 - 13329
    - HOUSLAY, MDSULLIVAN, MBOLGER GB, Adv. Pharmacol., (19980000), vol. 44, pages 225 - 342
    - VEBER, D. F. et al., J. Med. Chem., (20020000), vol. 45, pages 2615 - 2623
    - LIPINSKI, C. A., Drug Discovery Today: Technologies, (20040000), vol. 1, pages 337 - 341
    - THOMPSON, W. J.APPLEMAN, M. M., Biochemistry, (19710000), vol. 10, pages 311 - 316
    - MARCHMONT, R. J.HOUSLAY, M. D., Biochem J, (19800000), vol. 187, pages 381 - 92
    - LANIA AMANTOVANI GSPADA A, Ann Endocrinol (Paris), (20120000), vol. 73, pages 73 - 75
    - THOMPSON, M. D., Methods Mol. Biol., (20080000), vol. 448, pages 109 - 137
    - WEINSTEIN LSLIU JSAKAMOTO AXIE TCHEN M, Endocrinology, (20040000), vol. 145, pages 5459 - 5464
    - LANIA AMANTOVANI GSPADA A, Eur J Endocrinol, (20010000), vol. 145, pages 543 - 559
    - DUPREZ, L., Nat. Genet., (19940000), vol. 7, pages 396 - 401
    - BIEBERMANN, H., J. Clin. Endocrinol. Metab., (20010000), vol. 86, pages 4429 - 4433
    - KARGES, B., J. Endocrinol., (20050000), vol. 186, pages 377 - 385
    - ARTURI, F. et al., Exp. Clin. Endocrinol. Diabetes, (19980000), vol. 106, pages 234 - 236
    - PERSANI, L., J. Clin. Endocrinol. Metab., (20000000), vol. 85, pages 2872 - 2878
    - CALVI, L.M.SCHIPANI, E., J. Endocrinol. Invest., (20000000), vol. 23, pages 545 - 554
    - LATRONICO, A.C., J Clin. Endocrinol. Metab., (19950000), vol. 80, pages 2490 - 2494
    - KOSUGI, S., Hum. Mol. Genet., (19950000), vol. 4, pages 183 - 188
    - TRITOS, N. A.BILLER, B. M., Discov. Med., (20120000), vol. 13, pages 171 - 179
    - MASOUMI, A., Drugs, (20070000), vol. 67, pages 2495 - 2510
    - YAMAGUCHI, T., Kidney Int, (20000000), vol. 57, pages 1460 - 1471
    - WALLACE, D. P., Biochim. Biophys. Acta, (20110000), vol. 1812, pages 1291 - 1300
    - TORRES, V. E., Nat. Med., (20040000), vol. 10, pages 363 - 364
    - GATTONE, V. H. et al., Nat. Med., (20030000), vol. 9, pages 1323 - 1326
    - BELIBI, F. A.EDELSTEIN, C. L., Expert Opin. Investig. Drugs., (20100000), vol. 19, pages 315 - 328
    - SUSSMAN, C. R.WARD, C. J.LEIGHTNER, A. C.SMITH, J. L.AGARWAL, R.HARRIS, P. C.TORRES, V. E., J. Am. Soc. Nephrol., (20140000), vol. 25, pages 2222 - 2230
    - SUN, Y.ZHOU, H.YANG, B-X., Acta Pharmacologica Sinica, (20110000), vol. 32, pages 805 - 816
    - STRAZZABOSCO, M.SOMLO, S., Gastroenterology, (20110000), vol. 140, pages 1855 - 1859
    - GEVERS, T. J.DRENTH, J. P., Curr. Opin. Gastroenterol., (20100000), vol. 27, pages 294 - 300
    - JANSSEN, M. J., J. Hepatol., (20100000), vol. 52, pages 432 - 440
    - GONG, A.Y., Am. J. Physiol. Cell. Physiol., (20030000), vol. 284, pages C1205 - 1214
    - MASYUK, T.V. et al., Gastroenterology, (20070000), vol. 132, pages 1104 - 1116
    - MANCUSI, S. et al., J. Nephrol., (20130000), vol. 26, pages 207 - 12
    - MA, PNAS, (20070000), vol. 104, page 20386
    - DIAZ, A.DANON, M.CRAWFORD, J., J. Pediatr. Endocrinol. Metab., (20070000), vol. 20, pages 853 - 880
    - AHUJA et al., Critical Reviews in Microbiology, (20040000), vol. 30, pages 187 - 196
    - AGARWAL et al., Nature, (20090000), vol. 460, pages 98 - 102
    - AANDAHL, E. M., FASEB J, (19980000), vol. 12, pages 855 - 862
    - NAYJIB, B., The Open Immunology Journal, (20080000), vol. 1, pages 20 - 24
    - HOLM, A. M., J. Immunol., (20030000), vol. 170, pages 5772 - 5777
    - BRECKLER, M. et al., Cell. Signal., (20110000), vol. 23, pages 1257 - 1266
    - ALMAHARIQ, M., Mol. Pharmacol., (20130000), vol. 83, pages 122 - 128
    - BALJINNYAM, E. et al., Pigment Cell Melanoma Res, (20110000), vol. 24, pages 680 - 687
    - LORENZ, R., Pancreas, (20080000), vol. 37, pages 102 - 103
    - CHO et al., Crit Rev Oncog, (20110000), vol. 16, pages 37 - 46
    - CRANS-VARGAS et al., Blood, (20020000), vol. 99, pages 2617 - 9
    - SHANKAR et al., Cancer Cell, (20050000), vol. 7, pages 351 - 62
    - MERKLE et al., Cellular Signalling, (20110000), vol. 23, pages 507 - 515
    - MISRA, U. K.PIZZO, S. V., J. Cell. Biochem., (20090000), vol. 108, pages 998 - 1011
    - MISRA, U. K.PIZZO, S. V., J. Cell. Biochem., (20120000), vol. 113, pages 1488 - 1500
    - VEZZOSI, D.BERTHERAT, J., Eur. J. Endocrinol., (20110000), vol. 165, pages 177 - 188
    - LEVY, I., Curr. Opin. Pharmacol., (20110000), vol. 11, pages 689 - 697
    - AZEVEDO, M. F.STRATAKIS, C. A., Endocr. Pract., (20110000), vol. 17, pages 2 - 7
    - HORVATH, A., Nat Genet, (20060000), vol. 38, pages 794 - 800
    - HORVATH, A., Cancer Res, (20060000), vol. 66, pages 11571 - 11575
    - LIBE, R et al., Clin. Cancer Res., (20080000), vol. 14, pages 4016 - 4024
    - HORVATH. A., Cancer Res, (20090000), vol. 69, pages 5301 - 5306
    - HORVATH, A.MERICQ, V.STRATAKIS, C. A. N., Engl. J. Med., (20080000), vol. 358, pages 750 - 752
    - HORVATH, A. et al., Eur. J. Hum. Genet., (20080000), vol. 16, pages 1245 - 1253
    - LIBE, R., J. Clin. Endocrinol. Metab., (20110000), vol. 96, pages E208 - 214
    - The Practice of Medicinal Chemistry, (20030000), pages 561 - 585
    - LEINWEBER, Drug Metab. Res., (19870000), vol. 18, page 379
    - Nat. Rev. Drug Discov., (20160000), vol. 15, no. 4, pages 219 - 21
    - LIANGCHEN, Expert Opinion in Therapeutic Patents, (20010000), vol. 11, no. 6, pages 981 - 986
    - H. LIEBERMANL. LACHMAN, Pharmaceutical Dosage Forms: Tablets, Marcel Dekker, (19800000), vol. 1
    - MAO, Z.STREETS, A. J.ONG, A. C. M., Am. J. Physiol. Renal Physiol., (20110000), vol. 300, no. 6, pages F1375 - F1384
    - HENDERSON, D. J. P.BYRNE, A.DULLA, K.JENSTER, G.HOFFMANN, R.BAILLIE, G. S.HOUSLAY, M. D., Br. J. Cancer, (20140000), vol. 110, pages 1278 - 1287
    - YATES, J Clin Invest, (19880000), vol. 81, pages 932 - 938
    - KRUSE, K.KRACHT, U., European Journal of Pediatrics, (19870000), vol. 146, pages 373 - 377
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.